Global impression of perceived difficulties in children and adolescents with attention-deficit/hyperactivity disorder: Reliability and validity of a new instrument assessing perceived difficulties from a patient, parent and physician perspective over the day

被引：18

作者：

Wehmeier P.M. ^{[1
]}

Schacht A. ^{[1
]}

Dittmann R.W. ^{[1
,2
]}

Döpfner M. ^{[3
]}

机构：

[1] Lilly Deutschland, Medical Department, Bad Homburg

[2] Department of Child and Adolescent Psychosomatic Medicine, University of Hamburg, Hamburg

[3] Department of Child and Adolescent Psychiatry, University of Cologne, Cologne

来源：

Child and Adolescent Psychiatry and Mental Health | / 2卷 / 1期

关键词：

ADHD Symptom; Atomoxetine; Patient Perspective; Child Health Questionnaire; Physician Perspective;

D O I：

10.1186/1753-2000-2-10

中图分类号：

学科分类号：

摘要：

Background: The objective of this analysis was to evaluate the psychometric properties of a brief scale developed to assess the degree of difficulties in children with Attention-Deficit/Hyperactivity Disorder (ADHD). The Global Impression of Perceived Difficulties (GIPD) scale reflects overall impairment, psychosocial functioning and Quality of Life (QoL) as rated by patient, parents and physician at various times of the day. Methods: In two open-label studies, ADHD-patients aged 6-17 years were treated with atomoxetine (target-dose 0.5-1.2 mg/kg/day). ADHD-related difficulties were assessed up to week 24 using the GIPD. Data from both studies were combined to validate the scale. Results: Overall, 421 patients received atomoxetine. GIPD scores improved over time. All three GIPD-versions (patient, parent, physician) were internally consistent; all items showed at least moderate item-total correlation. The scale showed good test-retest reliability over a two-week period from all three perspectives. Good convergent and discriminant validity was shown. Conclusion: GIPD is an internally consistent, reliable and valid measure to assess difficulties in children with ADHD at various times of the day and can be used as indicator for psychosocial impairment and QoL. The scale is sensitive to treatment-related change. © 2008 Wehmeier et al; licensee BioMed Central Ltd.

引用

共 49 条

[1]

Diagnostic and Statistical Manual of Mental Disorders, (2000)

[2]

Barkley R.A., Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder, J Clin Psychiatry, SUPPL. 12, pp. 10-15, (2002)

[3]

Biederman J., Faraone S.V., Attention-deficit hyperactivity disorder, Lancet, 366, pp. 237-248, (2005)

[4]

Escobar R., Soutullo C.A., Hervas A., Gastaminza X., Polavieja P., Gilaberte I., Worse quality of life for children with newly diagnosed attention-deficit/hyperactivity disorder, compared with asthmatic and healthy children, Pediatrics, 116, (2005)

[5]

Harpin V.A., The effect of ADHD on the life of an individual, their family, and community from preschool to adult life, Arch Dis Child, SUPPL. 1, (2007)

[6]

Klassen A.F., Miller A., Fine S., Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder, Pediatrics, 114, (2004)

[7]

Matza L.S., Rentz A.M., Secnik K., Swensen A.R., Revicki D.A., Michelson D., Spencer T., Newcorn J.H., Kratochvil C.J., The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder, J Dev Behav Pediatr, 25, pp. 166-174, (2004)

[8]

Riley A.W., Spiel G., Coghill D., Dopfner M., Falissard B., Lorenzo M.J., Preuss U., Ralston S.J., Factors related to Health-Related Quality of Life (HRQoL) among children with ADHD in Europe at entry into treatment, Eur Child Adolesc Psychiatry, SUPPL. 1, (2006)

[9]

Sawyer M.G., Whaites L., Rey J.M., Hazell P.L., Graetz B.W., Baghurst P., Health-related quality of life of children and adolescents with mental disorders, J Am Acad Child Adolesc Psychiatry, 41, pp. 530-537, (2002)

[10]

Jensen P.S., Hinshaw S.P., Swanson J.M., Greenhill L.L., Conners C.K., Arnold L.E., Abikoff H.B., Elliott G., Hechtman L., Hoza B., March J.S., Newcorn J.H., Severe J.B., Vitiello B., Wells K., Wigal T., Findings from the NIMH multimodal treatment study of ADHD (MTA): Implications and applications for primary care providers, Dev Behav Pediatrics, 22, 1, pp. 60-73, (2001)

← 1 2 3 4 5 →